Company intelligence / Profile preview
WeInnovate Biosolutions
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
Overview
The company has developed ISO-certified antimicrobial solutions such as Silvo Guard Antimicrobial Foley Catheter and Silvo Clean Hand Sanitizer to reduce the incidence of hospital-acquired infections. Their technology aims to accelerate wound healing and prevent microbial contamination of medical devices. They have received grants from Biotechnology Industry Research Assistance Council for innovation in infection prevention.[2][3][4][5] No published clinical trial results found.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Antimicrobial solution (for medical devices and surfaces)Device (antimicrobial catheters)Small molecule (antimicrobial agents in formulations)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on WeInnovate Biosolutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WeInnovate Biosolutions.